Skip to Content
Print Share

Drug Interactions between melatonin and Trileptal

This report displays the potential drug interactions for the following 2 drugs:

  • melatonin
  • Trileptal (oxcarbazepine)

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between melatonin and Trileptal. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

melatonin

A total of 64 drugs are known to interact with melatonin.

Trileptal

A total of 522 drugs are known to interact with Trileptal.

Drug and food interactions

Moderate

OXcarbazepine food

Applies to: Trileptal (oxcarbazepine)

Alcohol can increase the nervous system side effects of OXcarbazepine such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with OXcarbazepine. Do not use more than the recommended dose of OXcarbazepine, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.

Switch to professional interaction data

Minor

melatonin food

Applies to: melatonin

Information for this minor interaction is only available at a professional reading level.

For clinical details see professional interaction data.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See Also

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer